| Fibromyalgia and Nitric Oxide - References |
 |
 |
|
1. Pall M. L. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypoth 2001;57:139-145. 2. Smith J. D., Terpening C. M., Schmidt S. O. F., Gums J. G. Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacotherapy 2001;35:702-706. 3. Sörensen J., Bengtsson A., Bäckman E., Henriksson K. G., Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995;24:360-365. 4. Nicolodi M., Volpe A. R., Sicuteri F. Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues. Cephalalgia, 1998;18: 41-44. 5. Graven Nielsen T., Aspegren Kendall S., Henriksson K. G. et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000:85:483-91. 6. Buskila D. Fibromyalgia, chronic fatigue syndrome and myofascial pain syndrome. Curr Opin Rheumatol 2001;13:117-127. 7. . Larson A. A., Giovengo S. L., Russell I. J., Michalek J. E. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 2000;87:201-211. 8. Liu T., Knight K. R., Tracey D. J. Hyperalgesia due to nerve injury role of peroxynitirte. Neuroscience 2000;97:125-131. 9. Pall M. L. Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndr 2000:7(4):45-58. 10. Eisinger J., Zakarian H., Pouly F., Plantamura A., Ayavou T. Protein peroxidation, magnesium deficiency and fibromyalgia. Magnes Res 1994;7:285-288. 11. Eisinger J., Gandolfo C., Zakarian H., Ayavou T. Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 1997;5(4);5-16. 12. Rauhala P., Chiueh C. C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998;12:165-173. 13. Pall M. L. Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. J Chronic Fatigue Syndr 2001:8(2);39-44. 14. Gebhard F., Nüssler A. K., Rösch M., Pfetsch H., Kinzl L., Brückner U. B. Early posttraumatic increase in production of nitric oxide in humans. Shock 1998;10:237-242.
|
|||
| Last Updated on Friday, 29 June 2007 18:10 |
